Stem cell-derived exosome production in stirred-tank bioreactors

Written by Eppendorf

Over the last several years there has been increasing interest in the therapeutic potential of mesenchymal stem cell (MSC)-derived exosomes in regenerative medicine. With many studies demonstrating their potential therapeutic benefits across a wide spectrum of diseases, the focus has now shifted onto the logistics behind manufacturing these exosomes.

Stirred-tank bioreactors provide an ideal setting to tightly control and monitor the production of exosomes, as well as the scalability, to produce increasing amounts. However, using stirred-tank bioreactors to cultivate stem cells requires profound knowledge and precise control of the process.

In this webinar, explore the benefits of using stirred-tank bioreactors in the cultivation of stem cells for exosome production. Additionally, hear from experts at Eppendorf as they share their knowledge on their developmental process using the DASbox® Mini Parallel Bioreactor System, and how they scaled-up the process to 1 L with their newest parallel bioreactor control system, the SciVario® twin.


This article is part of the RegMedNet Spotlight on acellular regenerative medicine. Click here to view the full feature and discover expert insights on this >>>